Best HIFU for prostate cancer treatment Doctors Worldwide — TOP 22

Prof. Merimsky leads the Unit for Orthopedic Oncology at Sourasky Medical Center, specializing in advanced prostate cancer treatments like HIFU.

• Over 41 years of experience of experience in oncology
• Fellowship in soft tissue and bone sarcoma at Institut Gustave Roussy, Paris
• Member of ESMO Sarcoma group faculty
• Published extensively on oncology outcomes

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Dai Haiyan is the President and Chief Physician of Gynecology at Shanghai Tongji Hospital. He holds a Level IV certification in laparoscopic surgery. This is the highest proficiency level for minimally invasive procedures. Dr. Dai completed specialized training at the University of Oslo Cancer Hospital in Norway.

• Expert in uterus-preserving treatment for endometriosis and complex gynecological conditions.
• Performs pelvic floor reconstruction and vaginal reconstructive surgery.
• Mentors graduate students as a Master’s Supervisor at Fudan University.
• Specializes in hysteroscopic and laparoscopic minimally invasive techniques.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Solak specializes in treating various cancers, including prostate cancer, with training from Hacettepe University Cancer Institute.

• Completed fellowship at Cancer Institute of Hacettepe University
• Worked at The University of Texas MD Anderson Cancer Center
• Experienced in treating breast, testicular, ovarian, lung, and gastrointestinal cancers

Prof. Jack Baniel leads uro-oncology research and performs advanced prostate cancer surgeries at Rabin Medical Center. He specializes in nerve-sparing techniques for better patient outcomes.

• Professor and Chief of Urology with extensive clinical experience
• Published over 100 scientific articles on uro-oncology
• Member of European and American urology associations
• Participates in global clinical research studies
• Founder of oncourological Department at Beilinson Hospital

Dr. Alemdar specializes in medical oncology with a focus on prostate cancer treatment at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University – a leading medical institution in Turkey

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is among the first five experts globally to publish data on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed a fellowship in laparoscopic urology at Heidelberg University, Germany.

• Pioneered combined PRP and stem cell penile therapy in Turkey.
• Developed a certified surgical technique for penile circumference improvement.
• Performs robotic prostatectomies and kidney-sparing surgeries for cancer treatment.
• Serves as an instructor for the International Society for Stem Cells Applications.

Dr. Shruti Kate trained at Tata Memorial Hospital – India's top cancer center – specializing in medical oncology with a focus on genitourinary cancers.

• Expertise in lung, breast, and genitourinary cancers
• Special interest in immunotherapy for advanced cancers
• Presented research at World Conference on Lung Cancer
• Member of ASCO, ESMO, and other leading oncology societies

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

30 years of experience of surgical oncology experience with 50,000+ cancer surgeries performed – Dr. Nagarkar focuses on improving patients' quality of life.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Specializes in Breast and Thoracic Surgical Oncology
• Involved in 200+ clinical trials
• Professor for DNB Superspecialty Surgical Oncology

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Chaitainya Borde has handled over 30,000 PET scans and 1,000 thyroid cancer patients, bringing deep expertise to prostate cancer treatment at HCG Manavata Cancer Centre.

• 11 years of experience of experience in nuclear medicine
• Specializes in radioiodine and Lu-177 RN therapies
• Published papers in medical journals
• Proficient in PET-CT scans and nuclear cardiology